Wolf Konrad, Meier-Meitinger Martina, Bergler Tobias, Castrop Hayo, Vitzthum Helga, Riegger Günter A J, Kurtz Armin, Krämer Bernhard K
Klinik und Poliklinik für Innere Medizin II, Klinikum der Universität Regensburg, 93042, Regensburg, Germany.
Pflugers Arch. 2003 Sep;446(6):665-71. doi: 10.1007/s00424-003-1098-8. Epub 2003 May 21.
In the past few years the pivotal role of kidney Cl(-)channels (ClC-K) channels in maintaining salt and water homeostasis in the kidney has been established. The aim of the present study was to investigate the influence of the loop diuretic furosemide on the gene expression of the kidney chloride channel ClC-K1 and its recently described functional subunit barttin. Male Sprague Dawley rats received the loop diuretic furosemide (12 mg/kg/day) for 6 days. Rats had free access to 0.9% NaCl, 0.1%KCl solution to prevent volume depletion. Localisation and regulation of ClC-K1 and barttin mRNA was analysed by RNase protection and in situ hybridisation. Nephron-specific regulation was investigated by microdissection and real-time PCR quantification. In furosemide-treated rats ClC-K1 mRNA decreased to half in the inner medulla. In the renal cortex and outer medulla ClC-K1 mRNA levels were weak and did not change. Under furosemide treatment barttin mRNA was regulated in parallel with ClC-K1 mRNA. A significant mRNA decrease occurred after furosemide treatment in inner medulla (0.50 fold), whereas cortical and outer medulla levels remained unaffected. (35)S in situ hybridisation confirmed the regulation and distribution seen in the RNase protection assay experiments. Microdissection of the inner medullary collecting duct and thin limb of Henle's loop followed by real-time PCR revealed that CLC-K1 and barttin mRNA regulation in inner medulla was limited to the thin limb; mRNA levels in collecting ducts were not affected by furosemide treatment. Our findings imply that during furosemide treatment selective down-regulation of ClC-K1 and barttin mRNAs in thin limb plays a role in maintaining salt and water homeostasis.
在过去几年中,肾脏氯离子通道(ClC-K)在维持肾脏盐和水平衡方面的关键作用已得到确认。本研究旨在探讨袢利尿剂呋塞米对肾脏氯离子通道ClC-K1及其最近发现的功能亚基barttin基因表达的影响。雄性Sprague Dawley大鼠接受袢利尿剂呋塞米(12 mg/kg/天)处理6天。大鼠可自由饮用0.9% NaCl、0.1% KCl溶液以防止容量耗竭。通过核糖核酸酶保护法和原位杂交分析ClC-K1和barttin mRNA的定位与调控。通过显微切割和实时PCR定量研究肾单位特异性调控。在接受呋塞米处理的大鼠中,内髓质中ClC-K1 mRNA减少至一半。在肾皮质和外髓质中,ClC-K1 mRNA水平较低且未发生变化。在呋塞米处理下,barttin mRNA与ClC-K1 mRNA平行调控。呋塞米处理后,内髓质中出现显著的mRNA减少(0.50倍),而皮质和外髓质水平未受影响。(35)S原位杂交证实了核糖核酸酶保护试验中观察到的调控和分布情况。对内髓质集合管和亨氏袢细段进行显微切割,随后进行实时PCR分析,结果显示内髓质中CLC-K1和barttin mRNA的调控仅限于细段;集合管中的mRNA水平不受呋塞米处理的影响。我们的研究结果表明,在呋塞米治疗期间,细段中ClC-K1和barttin mRNA的选择性下调在维持盐和水平衡中发挥作用。